Genmab A (GMAB) Interest Coverage Ratio (2019 - 2026)

Genmab A (GMAB) posted Interest Coverage Ratio of 1.2 for Q1 2026, up 79.74% on a QoQ basis from 5.92 in Q3 2025, and up 71.28% year-over-year from 0.7 in Q1 2025.

Genmab A (GMAB) Interest Coverage Ratio (2019 - 2026) Analysis & Trends

Genmab A's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 1.2 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 71.28% year-over-year to 1.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.24 (up 47.03% YoY) and the FY2025 annual result came in at 3.96, up 18.53% from the prior year.
  • Interest Coverage Ratio was 1.2 for Q1 2026 at Genmab A, up from 5.92 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 1.2 in Q1 2026 and bottomed at 146.33 in Q4 2024.
  • A 3-year average of 21.64 and a median of 4.13 in 2025 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2025 — Interest Coverage Ratio slumped 61.96% — and 2026, when it surged 71.28%.
  • Genmab A's Interest Coverage Ratio stood at 146.33 in 2024, then surged by 95.95% to 5.92 in 2025, then soared by 79.74% to 1.2 in 2026.
  • Business Quant data shows GMAB's Interest Coverage Ratio at 1.2 in Q1 2026, 5.92 in Q3 2025, and 4.09 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Genmab A 1.89 Bn 366.92 Mn 831.00 Mn -1.20

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.20
Sep 30, 2025 -5.92
Jun 30, 2025 -4.09
Mar 31, 2025 -4.18
Dec 31, 2024 -146.33
Sep 30, 2024 -3.66
Jun 30, 2024 -4.40
Mar 31, 2024 -3.31
Sep 30, 2020 -2,383.21 Bn
Dec 31, 2019 -215.22